Artificial intelligence-powered payer intelligence startup Anomaly Insights has launched a new tool aimed at providing managed care executives with evidence…

Thanks to advances in cancer treatment and early detection, the population of cancer survivors continues to grow, reaching more than…

Bio‑Techne Corporation, a global provider of life science tools, reagents, and diagnostic products, and Refeyn, a pioneer in mass photometric…

The FDA approved 46 novel drugs in 2025 across oncology, infectious diseases, and rare disorders, offering key insights for regulatory and development strategies in 2026.

Get the health information and medications you need every weekday with STAT’s free newsletter Morning Rounds. Sign up here. good…